- Open Access
Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice
© The Author(s). 2017
Received: 24 August 2017
Accepted: 8 December 2017
Published: 22 December 2017
Numerous toxicological studies have focused on injury caused by exposure to single types of nanoparticles, but few have investigated how such exposures impact a host’s immune response to pathogen challenge. Few studies have shown that nanoparticles can alter a host’s response to pathogens (chiefly bacteria) but there is even less knowledge of the impact of such particles on viral infections. In this study, we performed experiments to investigate if exposure of mice to single-walled carbon nanotubes (SWCNT) alters immune mechanisms and viral titers following subsequent influenza A virus (IAV) infection.
Male C57BL/6 mice were exposed to 20 μg of SWCNT or control vehicle by intratracheal instillation followed by intranasal exposure to 3.2 × 104 TCID50 IAV or PBS after 3 days. On day 7 mice were euthanized and near-infrared fluorescence (NIRF) imaging was used to track SWCNT in lung tissues. Viral titers, histopathology, and mRNA expression of antiviral and inflammatory genes were measured in lung tissue. Differential cell counts and cytokine levels were quantified in bronchoalveolar lavage fluid (BALF).
Viral titers showed a 63-fold increase in IAV in SWCNT + IAV exposed lungs compared to the IAV only exposure. Quantitation of immune cells in BALF indicated an increase of neutrophils in the IAV group and a mixed profile of lymphocytes and neutrophils in SWCNT + IAV treated mice. NIRF indicated SWCNT remained in the lung throughout the experiment and localized in the junctions of terminal bronchioles, alveolar ducts, and surrounding alveoli. The dual exposure exacerbated pulmonary inflammation and tissue lesions compared to SWCNT or IAV single exposures. IAV exposure increased several cytokine and chemokine levels in BALF, but greater levels of IL-4, IL-12 (P70), IP-10, MIP-1, MIP-1α, MIP-1β, and RANTES were evident in the SWCNT + IAV group. The expression of tlr3, ifnβ1, rantes, ifit2, ifit3, and il8 was induced by IAV alone but several anti-viral targets showed a repressed trend (ifits) with pre-exposure to SWCNT.
These findings reveal a pronounced effect of SWCNT on IAV infection in vivo as evidenced by exacerbated lung injury, increased viral titers and several cytokines/chemokines levels, and reduction of anti-viral gene expression. These results imply that SWCNT can increase susceptibility to respiratory viral infections as a novel mechanism of toxicity.
Rapid advancement in nano-scale material synthesis has led to the development of numerous and diverse types of nanomaterials (NM) that are being widely utilized in the industrial and consumer product sectors . One type of NM, carbon nanotubes (CNT), have strong carbon-carbon (C-C) sigma bonds and sp2 hybridization that form nanoparticles with high tensile strength and superior thermal and electrical properties . Such properties have led to the use of CNT in electrodes, supercapacitors, catalysis, filters and membranes, sensors, and are being explored for biomedical applications [3–5]. The implementation of CNT-related products, research publications, and patents continues to increase and De Volder and colleagues report the worldwide production capacity of CNT has increased more than 10 fold since 2006 .
Potential environmental exposures to CNT is likely to arise through release during various stages of product lifecycles that include manufacturing, product use, end-of-life and waste leaching through ingestion, inhalation, and direct dermal contact . Due to their ultra-small size and based on our knowledge of particulate deposition in the respiratory tract, CNT are accessible to deeper parts of the airway, supporting inhalation as a critical route of exposure [7, 8]. Detectable levels of CNT have been recently measured in air and surfaces in industrial settings where these materials are being utilized in manufacturing products and adverse biological effects have been found among these workers [9–11]. Moreover, several in vivo studies report that different types of CNT can induce varied adverse pulmonary effects including sub-chronic tissue damage, fibrogenesis, granulomatous changes, impaired clearance, robust inflammation, airway hyper-reactivity, and cardiopulmonary consequences, among others [12–14]. Few studies, however, have investigated whether pulmonary exposure to CNT alters the hosts’ susceptibility to subsequent pathogen infections, particularly respiratory viruses. In fact, our group is the first to demonstrate that CNT modulate typical cellular responses to influenza virus resulting in enhanced infectivity . Specifically, we reported that pre-exposure of human small airway epithelial cells to single-walled carbon nanotubes (SWCNT) results in significant increases in pandemic influenza A virus H1N1 (IAV) titers . Noteworthy, these particular lung cells are found in the distal portion of the human respiratory tract and IAV infections of the lower respiratory tract are associated with increased disease severity , a scenario that is likely true for other respiratory pathogens.
Several lines of epidemiological evidence support that inhalation of particulates generated in the workplace or ambient environment result in increased incidence and severity of respiratory infections that carry significant health and economic burden . In the U.S. alone, upper respiratory infections caused by non-influenza viruses are responsible for 500 million infections annually, a loss of 40 billion dollars and 40–100 million school and work days . Populations exposed to particulates, such as those present in ambient air pollution (PM2.5, diesel exhaust particulates, secondary organic aerosols), and the workplace (silica, particulates in welding fumes) are reported to have higher infection rates and increased emergency room visits [19–21]. Similar in size and structure to some of these particulates, CNT are suspected to possess the same ability to exacerbate pathogenic infections. A few studies have reported that inhalation of CNT can inhibit bacteria phagocytosis and clearance with enhanced pulmonary inflammation and fibrosis [2, 22, 23]; sequential exposure to SWCNT and Listeria monocytogenes enhanced pulmonary inflammation and infectivity in mice ; and helical CNT enhanced the immune response and inhibited macrophage-mediated phagocytosis of Pseudomonas aeruginosa . In a more recent study, NM were shown to reactivate latent herpesvirus in mouse and human cells .
While these studies provide a rationale for investigating the impact of CNT on pathogenic infections, we are the only group to date that has investigated how SWCNT increase IAV infections specifically. Our previous work provided evidence that SWCNT inhibited IAV-induced expression of several antiviral and inflammatory markers (CCL5, IFIT2, IFIT3)  but these observations were limited to in vitro studies in lung epithelial cells. Here we investigated the effect of SWCNT exposure on subsequent pulmonary infection with IAV, assessing viral titers, antiviral, and immune responses in an in vivo mouse model. Overall, we report that pre-exposure to SWCNT results in significant enhancement of IAV titers while exacerbating lung tissue inflammation and enhanced expression of several relevant cytokines and chemokines.
SWCNT suspension preparation
Pristine SG65i SWCNT were provided by SouthWest Nanotechnologies Inc. (SWeNT). The SG65i are a mixture of primarily semi-conductive and chirality-enriched non-functionalized CNTs characterized by our group, measuring 0.78 nm in diameter and <4% cobalt and molybdenum . All SWCNT suspensions were prepared in 2% sodium deoxycholate (SDC) and dialyzed in 1% pluronic F68 (v/v in deionized water, Sigma) using protocols similar to methods previously described  to maintain innate fluorescent properties. Briefly, dry SG65i were suspended with 2% SDC to 1 mg/mL and sonicated (Sonifier™ S-450 Digital Ultrasonic Cell Disruptor/Homogenizer, Branson Ultrasonics, Danbury, CT) at 30–50 watt power for 20 min in an ice bath. SWCNT were then diluted in 2% sodium cholate, and their absorbance read at 775 nm (SOFTmax Pro4.0, Synergy H1, Biotek) . The remaining SWCNT stock was centrifuged at 14,100 rpm for 20 min and then supernatant was collected and sonicated at 30 watts for 10 min. The suspension was transferred into 3 mL dialysis catridges (3500 MWCO, Thermo-Scientific) which were soaked in 1% pluronic for surfactant exchange. The dialysis process continued for 3 consecutive days and the absorbance measured at the end of dialysis. Final concentration of SWCNT was calculated as follows: starting concentration × (after dialysis absorbance/pre-dialysis absorbance). The SWCNT suspension was re-sonicated at 30 watts for 1 min before use.
SWCNT suspension characterization
Time dependent hydrodynamic radii (HDR) of SDC and pluronic modified SWCNT in water were monitored with time resolved dynamic light scattering (TRDLS). The SWCNT concentration for the DLS measurements was 10 mg/L. A 22 mW 632 nm HeNe laser incorporated ALV/CGS-3 compact goniometer system (ALV-Laser GmbH, Langen/Hessen, Germany) with QE APD detector (photomultipliers of 1:25 sensitivity) was employed to monitor size evolution every 15 s for 48 h. The TRDLS experiments were performed at 37 °C with 2 mL sample in a borosilicate glass vial, which was cleaned thoroughly with 2% extran solution. The vial was vortexed for 10s before inserting in the toluene-filled sample vet of the goniometer system. The scattered light was collected at 90° and analyzed using an auto cross-correlator to calculate average HDR. The electrophoretic mobility (EPM) of SWCNT suspensions was measured using a Möbiuζ (Wyatt Technology, Santa Barbara, CA) at 25 °C and 30 psi. For each measurement, 1 mL of the suspension was introduced into a flow through cell using a 1 mL syringe. Five EPM values were collected for each suspension.
Influenza virus preparation and titration
Influenza virus H1N1 strain A/Mexico/4108/2009 was kindly provided by Drs. Gary Heil and Gregory Gray and was propagated in MDCK cells in serum-free medium with 1 or 0.1 μg/ml L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin as previously described . To quantify the number of virus particles we calculated TCID50 values using a standard assay . Briefly, part of the right lung tissue of each mouse was weighed and homogenized using disposable tissue grinders (VWR, Radnor, PA) in advanced DMEM media (Invitrogen, Carlsbad, CA) containing 1% penicillin-streptomycin-neomycin antibiotic mixture (Fisher, Waltham, MA) and 1% L-Glutamax (Fisher, Waltham, MA). To perform the titer assays, MDCK cells were seeded in 96 well plates and serial dilutions (10−1, 10−2, 10−3, 10−4, 10−5, 10−6) of virus stock and lung tissue homogenates were added to cell monolayers. Cells were incubated at 33 °C and monitored for cytopathic effects (CPE) by light microscopy 5 days post infection. Each well that displayed CPE was scored as positive. The TCID50 was calculated as the dilution of virus at which 50% of the cell cultures were infected.
Male C57BL/6 mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and housed in plastic cages and provided with water and feed ad libitum at 25 °C, 50% humidity and 12/12 h light/dark cycle at the Animal Care Service Facility. All animals were acclimated in ambient conditions for a week before any treatment were given. The mice were treated humanely according to the NIH Guide for the Care and Use of Laboratory Animals and all protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Florida.
Preliminary IAV dose finding study
Twenty mice at the age of 12 weeks were randomly assigned into four groups (N = 5). On day 0, animals were anesthetized with a cocktail of ketamine (100 mg/kg x bw) and xylazine (5 mg/kg x bw) (Patterson Veterinaries Inc., Charlotte, NC) through intraperitoneal injection. After anesthesia, the mice were given 50 μL of different doses of IAV (100, 102, and 104 TCID50 per animal) or phosphate-buffered saline (PBS) through intranasal aspiration. Daily body weight and clinical signs of infection were monitored daily. Mice were euthanized on days 3 and 7 with intraperitoneal injection of 0.2 mL fatal plus solution (VorTech Pharmaceuticals). Mouse lungs were collected and frozen in liquid nitrogen for virus titration.
Sequential exposures of SWCNT and virus to mice
Forty mice at the age of 12 weeks were randomly assigned into four groups (N = 10) control, SWCNT only, IAV only, and SWCNT + IAV. Mice were anesthetized as described above prior to positioning each animal on a rodent-tilting work station and inoculated with 40 μL of either SWCNT (20 μg per animal) or control vehicle at the entrance of the trachea on day 0. On day 3, animals received 50 μL of either IAV (3.2 × 104 TCID50 per animal) or PBS through intranasal aspiration. Animals were weighed and monitored for clinical signs daily. On day 7, all animals were euthanized with 0.2 mL fatal plus solution.
Immune cell identification in bronchoalveolar lavage fluid (BALF)
Following euthanasia, mouse lungs were lavaged with 1 mL cold PBS and the recovered fluid was collected and immediately placed on ice. BALF volumes were recorded and the total number of cells quantified by counting on a haemocytometor. The volume of BALF required for 25,000 cells total per sample was spun onto glass slides using a cytospin (ThermoFisher). All slides were stained using a HEMA III kit (ThermoFisher) and 200 cells per slide were counted and identified as monocytes, lymphocytes, neutrophils, eosinophils, or basophils. All samples were counted duplicate and the average values were calculated.
Histopathology and IAV immunohistochemistry
The left lung of each animal was perfused with freshly prepared 4% paraformaldehyde (PFA) in PBS at pH 7.4, then excised and stored in the same PFA solution. Fixed lung tissues were embedded in paraffin wax and sectioned at approximately 5 μm. Sections were then deparaffinized and stained with hematoxylin and eosin (H&E) for histopathologic and morphometric analysis by a certified pathologist (W.L.C.). Each of 2 lung sections from the left lung of each mouse will be assessed for bronchitis, bronchiolitis, and interstitial pneumonia. In addition to qualitative histopathology assessment, volume density of pneumonia will be calculated by digitizing morphometry as described . Density of H1N1 viral antigen-positive cells in area of pneumonia and percentage of viral antigen-positive bronchioles will be calculated . Additional paraffin sections for H1N1 antigen immunohistochemistry will be mounted on charged slides, de-paraffinized and rehydrated prior heat-induced epitope retrieval in Tris-EDTA, pH 9 at 95 °C for 20 min. Endogenous peroxidase activity will be quenched by treatment with 0.3% H2O2 in methanol for 30 min. Sections will be treated with horse blocking serum prior to incubation with goat anti-H1N1 (AB1074, Millipore, Billerica, MA) at 1:500. Bound antibody will be detected with an ImmPRESS anti-goat IgG-polymer detection kit (MP-7405, Vector Laboratories, Burlingame, CA) prior to peroxidase activity detection with Metal Enhanced DAB (3,3′-diaminobenzidine) Substrate Working Solution (Thermo Scientific, Rockford, IL) as described in the kit. Slides will be lightly stained with Harris hematoxylin.
Near infrared fluorescence (NIRF) imaging of SWCNT in lung tissue
H&E stained mouse lung sections were imaged using a custom NIRF system and the fluorescent signals were captured and processed by WinView software (Princeton Instruments, Trenton, NJ). All pictures presented were background subtracted and standardized (intensity range) as previously described . Final NIRF images were merged over corresponding brightfield pictures in Photoshop (Adobe).
Quantitation of cytokines and chemokines in BALF
Expression levels of 25 cytokines and chemokines (G-CSF, GM-CSF, IFNγ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17, IP-10, KC, MCP-1, MIP-1α, MIP-1β, MIP-2, RANTES, and TNFα) were quantified in BALF using the MILLIPLEX mouse cytokine / chemokine magnetic bead panel (Millipore) according to the manufacturer’s protocol. The samples were acquired on Luminex 200 system (Luminex) and the amount (ng/mL) was calculated using xPONENT software (Luminex).
Expression levels of immune- and anti-viral related genes in lung tissue
Changes in mRNA expression in SWCNT- and IAV-exposed mouse lungs was performed by real-time qRT-PCR as previously described . Briefly, frozen lung tissues (from the lavaged right lung lobe) were homogenized with RNA Stat-60 (Tel-Test) following manufacturer’s instructions. RNA pellets were reconstituted in RNA secure (Ambion) and incubated for 10 min at 60 °C to inactivate RNases. The resultant cDNA was amplified using validated primers (Additional file 1: Table S2) and probes specific to each gene target; ccl5, il8, ifit2. ifit3, ifnβ1, tlr3 (Applied Biosystems). Expression of GAPDH was employed for a standard housekeeping gene and all data is presented as normalized fold change in expression compared to controls using the ∆∆Ct method.
One-way ANOVA was used to compare the average mean of parameters described above unless indicated specifically among different treatment groups. Pair-wise comparisons were conducted by using Tukey’s test when equal variances were confirmed and Dunnett’s test for unequal variances. T-test was used to compare the difference of viral titer between IAV only group and SWCNT + IAV groups. Data were tested for normal distribution for one-way ANOVA and t-test. Data with non-normal distribution would be transformed to achieve normal distribution. Due to unequal sample size and non-normal distribution of data, immune cell counts and gene expression data were compared by using Kruskal-Wallis rank-sum test and pair-wise comparison were conducted by using Dunn’s multiple comparison test. Statistical differences were identified at P < 0.05.
Influenza A virus dose finding study in mice
SWCNT pre-exposure increased IAV titers in mice
Viral titers were quantified in mouse lung tissues revealing (Fig. 2D) 107 TCID50/g for the IAV only group which was consistent with our dose-finding study (Fig. 1) and previous reports which range from 105 to 107 TCID50/g post infection 3–4 days [30–32]. Strikingly, the titer in the co-exposed group of SWCNT + IAV reached 109 TCID50/g which was significantly elevated by 63 fold compared to the IAV only group.
SWCNT and IAV sequential exposure induced a mixed profile of immune cells in bronchoalveolar lavage fluid
SWCNT and IAV exposure increased pulmonary inflammation and lung injury
Localization of SWCNT in mouse lung tissue using near infrared fluorescence (NIRF)
In general, the NIRF signals were heterogeneously dispersed where nanotubes were visualized in dense areas of immune cell infiltration and pneumonia but also in less dense areas that corresponded to what appears to be individual or clusters of immune and epithelial cells. Interestingly, the dense areas of pneumonia induced by the SWCNT + IAV exposure contained some fluorescence signal but overall the SWCNT did not seem concentrated in these areas where the majority of IAV was detected. It is also worth noting that after 7 days, the SWCNT were still very apparent in the lung tissue. While degradation and clearance of the SWCNT was not quantified in this study, the images suggest some of the particles may be present in immune cells, but overall, they are not rapidly removed.
SWCNT modulate the production of cytokines and chemokines in IAV infected mice
SWCNT and IAV induced changes in gene expression
Here we report, for the first time, that pre-exposure of mice to SWCNT causes a significantly enhanced influenza virus titer in lung tissues. This observation is consistent with results of our previous in vitro study  where a significant increase in quantified virus was observed in lung epithelial cells pre-exposed to SWCNT prior to IAV infection. Several other in vivo studies have investigated the ability of chemicals or particulates to alter viral titers but results have been variable between agents. For example, geogenic PM10 exposure increased viral titers of influenza H3N1, leading to exacerbated inflammation and lung injury in BALB/c mice . Similarly, exposure to combustion derived PM resulted in the production of oxidative stress accompanied by increased influenza H1N1 infection with suppressed adaptive immune responses in neonatal rats . In contrast, exposure to diesel exhaust exacerbated lung inflammation and injury in mice in response to subsequent IAV infection without significantly increasing viral titers [51, 52] and a similar result was also observed for exposure to cigarette smoke [35, 45]. Consistent across these studies is the noted enhanced lung inflammation with pre-exposure to the particulates prior to viral infection despite the varied increase in titers. This may be partially explained by inherent differences in particulate properties and viruses, exposure times and virus quantitation methods. It is also likely that the particulates vary in their mechanisms of action at the molecular level, a notion that has not been extensively probed.
As expected, exposure to IAV alone resulted in an expected immune response whereby increased cell numbers, particularly neutrophils, were noted in BALF, numerous cytokines and chemokines were significantly increased, and tissues presented with severe interstitial pneumonia, infiltration of lymphocytes and neutrophils, bronchial lesions, and alveolar damage with edema, consistent with previous reports [35, 39, 43–49]. We also observed several significantly decreased cytokines by IAV infection, including IL-1α, IL-2, and IL-10, which vary in their repose to respiratory viruses in the literature. The levels of IL-1α has been shown to both increase and decrease in response to IAV infection [39, 44], which is likely a result of different virus strains as reported for H1N1 A/Cal/04/2009 vs. H1N1 A/Brisbane/59/2007. IL-2 and IL-10 levels were significantly decreased by IAV treatment in our study whereas other findings found no change in mouse BALF in response to IAV [39, 44, 45, 47]. Such discrepancies among studies might come from different virus strains, different time-points, and sensitivity of different protein assays.
Several anti-viral genes were also highly induced by IAV which supports the known function of these proteins in early host immune anti-viral defense mechanisms. For example, as a pattern recognition receptor (PRR), tlr3 senses double stranded viral RNA which initiates a series of downstream events that include activation of transcription factors NF-kβ and/or interferon regulatory factor (IRF) . These pathways lead to increased transcription of pro-inflammatory and anti-viral genes that include ifnβ1, Il-8, rantes, ifit2 and ifit3 . The IFITs directly inhibit viral replication through multiple mechanisms including decreasing translation initiation, binding uncapped RNA for PRR recognition, and sequestering specific viral RNAs or proteins from functioning normally . These proteins serve as a major anti-viral defense mechanism following infection.
The lack of a robust immune response following exposure to SWCNT alone, with respect to differential cell counts, cytokine and chemokine levels, and gene expression was surprising, although a moderate increase of lymphocytes in BALF was observed. These latter observations are in agreement with several studies showing increases in neutrophil and lymphocyte cell populations in response to SWCNT in animal models [37, 38, 56, 57]. The current literature varies when reporting on modulation of immune markers in SWCNT-exposed mice; only some studies have indicated significantly increased BALF cytokine (IL-1β, IL-4, IL-5, IL-6, IL-12) or chemokine levels (G-CSF, MIP-1, MCP-1, KC) [22, 38, 56]; while other reports showed no modulation of these, or other mediators . It has been suggested that nanotubes localize not with macrophages, but with CD11c positive dendritic cells, resulting in suppression of T cell responses . A similar result was also observed in mice exposed to multi-walled carbon nanotubes (MWCNT) that were subsequently stimulated with a mitogen . Interestingly, histopathological changes were quite evident in the SWCNT exposed group despite the lack of immune response (cytokines, genes) which presented as localized pneumonia, observations in line with reports showing that SWCNT induced pneumonitis with accumulation of pulmonary neutrophils and macrophages at peribronchiolar regions and alveoli in conjunction with fibrotic and granulomatous lesions 7 days post exposure [22, 37, 38].
We report several novel observations related to the combined SWCNT + IAV exposure group. First, a mixed immune cell profile was quantified in BALF which consisted of a significant increase in the number of neutrophils (IAV), lymphocytes (SWCNT) and several cytokines and chemokines. For example, there were significantly higher levels of MIP-1α and MIP-1β in the co-exposure group compared to IAV alone, which are known to be important chemotactic and pro-inflammatory factors that activate and recruit granulocytes, such as neutrophils, to sites of infection . Other enhanced immune proteins included IL-4 and IL-12 (p70) which are actively involved in T cell differentiation, activation or maturation while IP-10, MCP-1, and RANTES are chemoattractants that recruit T cells, among others, to sites of infection [44, 45, 47]. TNFα is also an important mediator of fever and systemic inflammation  and was also significantly increased in the co-exposure group. Such high levels of cytokines and chemokines paralleled with increased numbers of total immune cells in BALF and exacerbation of tissue inflammation indicating a more than additive immune response for many of the targets measured.
Second, examination of the tissues showed overlap in the nature of the lesions induced by the combined injury yet NIRF imaging analysis showed that the injury was not always affecting the same locations. This is consistent with notion that there was overlap in the nature of the lesions induced by the combined injury yet considerable differences in the magnitude of the lesions. While the mechanisms driving the overlapping yet unique injury profiles of SWCNT and IAV are not yet clear, a few reports have shown CNTs were also able to impair bacterial clearance and phagocytosis that led to worsened infection [2, 22]. A properly regulated immune response is essential for developing an effective defense that includes clearing pathogens and rebuilding damaged tissues ; however excessive inflammation can be problematic and detrimental [61, 62]. The enhanced immune response by SWCNT + IAV may dysregulate typical immune responses to IAV infection, leading to increased viral replication.
Third, imaging analysis supports that the SWCNT are not readily cleared. There are several reports that discuss the degradation of SWCNT by immune cell enzymes such as myeloperoxidase (MPO) and nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) [63, 64]. Interestingly, the degradation capacity of such enzymes varies depending on the SWCNT surface chemistry (pristine vs. oxidized) and coating (i.e. pluronic-PEG, bovine serum albumin (BSA), sodium dodecyl cholate (SDC)) and in fact, one report  showed that pluronic-PEG wrapped pristine SWCNT were effectively protected from degradation by MPO. As our SWCNT were prepared in pluronic, they may be less prone to degradation and clearance compared to other types and suspensions of nanotubes.
Fourth, the decreasing trends in mRNA expression of tlr3, ifit2, and ifit3 in lung tissue supports a repression of targeted anti-viral defenses which has only recently been reported by our group based on in vitro studies, although the repression was not as strong in vivo. There are likely several reasons that contribute to the lack of substantial repression in in vivo. These include: the expression changes of these genes might be cell-type specific (i.e. epithelial cells) and measurements of whole tissues may mask differences; we only analyzed one series of exposures, SWCNT for 3 days followed by IAV infection for 4 days, and it is possible that at earlier time-points, a greater difference could be observed due to the transient nature of transcription; moderate repression of these virus-responsive genes by SWCNT might still have a significant biological consequence on the cellular anti-viral defense mechanisms, which may partially explain the increased viral titers in the SWCNT + IAV exposed group.
Research directed at advancing our understanding of SWCNT pulmonary toxicity has shown these particles can induce robust inflammation, fibrosis, granulomas, and pre-cancerous lesions [37, 56, 65–67], but few have studied their influence on pathogen susceptibility. As a follow-up to our previous in vitro study, the present work confirms that SWCNT can increase IAV titers in vivo in concert with exacerbation of inflammation in lung tissues and mechanisms pointing towards modulation of key antiviral and inflammatory markers. Future studies should consider deeper mechanistic probing to elucidate a role for anti-viral proteins, such as IFITs, in SWCNT-induced lung toxicity.
The authors would like to thank Drs. Gregory Gray and Gary Heil for the influenza virus stocks and Dr. Shannon Wallet and Ms. Heather Sorenson for assistance with Luminex assay.
This work was supported by the National Institute of Health (R01HL114907 to TSA) and the University of Florida Research Foundation (to TSA) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
The manuscript was prepared through contributions of all authors. TSA, JAL, NBS conceived and designed the experiments. HC, XZ, JN, JCL, STH, SER, JHB, DD, and WLC performed the experiments: TSA, NBS, WLC, HC, and STH analyzed the data. TSA, HC, WLC and NBS wrote and edited the manuscript. All authors read and approved the final manuscript.
The mice were treated humanely according to the NIH Guide for the Care and Use of Laboratory Animals and all protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Florida (201408654).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Guzman KA, Taylor MR, Banfield JF. Environmental risks of nanotechnology: National Nanotechnology Initiative funding, 2000-2004. Environ Sci Technol. 2006;40:1401–7.View ArticlePubMedGoogle Scholar
- Walling BE, Kuang Z, Hao Y, Estrada D, Wood JD, Lian F, Miller LA, Shah AB, Jeffries JL, Haasch RT, et al. Helical carbon nanotubes enhance the early immune response and inhibit macrophage-mediated phagocytosis of Pseudomonas Aeruginosa. PLoS One. 2013;8:e80283.View ArticlePubMedPubMed CentralGoogle Scholar
- De Volder MF, Tawfick SH, Baughman RH, Hart AJ. Carbon nanotubes: present and future commercial applications. Science. 2013;339:535–9.View ArticlePubMedGoogle Scholar
- Tan A, Yildirimer L, Rajadas J, De La Pena H, Pastorin G, Seifalian A. Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine. Nanomedicine (Lond). 2011;6:1101–14.View ArticleGoogle Scholar
- Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, Abasi M, Hanifehpour Y, Joo SW. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 2014;9:393.View ArticlePubMedPubMed CentralGoogle Scholar
- Plazas-Tuttle J, Rowles LS, Chen H, Bisesi JH, Sabo-Attwood T, Saleh NB. Dynamism of stimuli-responsive Nanohybrids: environmental implications. Nano. 2015;5:1102–23.Google Scholar
- Rydman EM, Ilves M, Koivisto AJ, Kinaret PA, Fortino V, Savinko TS, Lehto MT, Pulkkinen V, Vippola M, Hameri KJ, et al. Inhalation of rod-like carbon nanotubes causes unconventional allergic airway inflammation. Part Fibre Toxicol. 2014;11:48.View ArticlePubMedPubMed CentralGoogle Scholar
- Chen PH, Hsiao KM, Chou CC. Molecular characterization of toxicity mechanism of single-walled carbon nanotubes. Biomaterials. 2013;34:5661–9.View ArticlePubMedGoogle Scholar
- Liao HY, Chung YT, Lai CH, Wang SL, Chiang HC, Li LA, Tsou TC, Li WF, Lee HL, WT W, et al. Six-month follow-up study of health markers of nanomaterials among workers handling engineered nanomaterials. Nanotoxicology. 2014;8(Suppl 1):100–10.View ArticlePubMedGoogle Scholar
- Liou SH, Tsai CS, Pelclova D, Schubauer-Berigan MK, Schulte PA. Assessing the first wave of epidemiological studies of nanomaterial workers. J Nanopart Res. 2015;17:413.View ArticlePubMedPubMed CentralGoogle Scholar
- Kuijpers E, Bekker C, Fransman W, Brouwer D, Tromp P, Vlaanderen J, Godderis L, Hoet P, Lan Q, Silverman D, et al. Occupational exposure to multi-walled carbon nanotubes during commercial production synthesis and handling. Ann Occup Hyg. 2016;60:305–17.View ArticlePubMedGoogle Scholar
- Jackson P, Jacobsen NR, Baun A, Birkedal R, Kühnel D, Jensen KA, Vogel U, Wallin H. Bioaccumulation and ecotoxicity of carbon nanotubes. Chem Cent J. 2013;7:b84.View ArticleGoogle Scholar
- Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol Appl Pharmacol. 2012;261:121–33.View ArticlePubMedPubMed CentralGoogle Scholar
- Kayat J, Gajbhiye V, Tekade RK, Jain NK. Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomedicine. 2011;7:40–9.View ArticlePubMedGoogle Scholar
- Sanpui P, Zheng X, Loeb JC, Bisesi JH Jr, Khan IA, Afrooz AR, Liu K, Badireddy AR, Wiesner MR, Ferguson PL, et al. Single-walled carbon nanotubes increase pandemic influenza a H1N1 virus infectivity of lung epithelial cells. Part Fibre Toxicol. 2014;11:66.View ArticlePubMedPubMed CentralGoogle Scholar
- Gerlach RL, Camp JV, Chu YK, Jonsson CB. Early host responses of seasonal and pandemic influenza a viruses in primary well-differentiated human lung epithelial cells. PLoS One. 2013;8:e78912.View ArticlePubMedPubMed CentralGoogle Scholar
- Castranova V, Schulte PA, Zumwalde RD. Occupational nanosafety considerations for carbon nanotubes and carbon nanofibers. Acc Chem Res. 2013;46:642–9.View ArticlePubMedGoogle Scholar
- Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–94.View ArticlePubMedGoogle Scholar
- Hatch GE, Boykin E, Graham JA, Lewtas J, Pott F, Loud K, Mumford JL. Inhalable particles and pulmonary host defense: in vivo and in vitro effects of ambient air and combustion particles. Environ Res. 1985;36:67–80.View ArticlePubMedGoogle Scholar
- Jakab GJ. Adverse effect of a cigarette smoke component, Acrolein, on pulmonary antibacterial defenses and on viral-bacterial interactions in the lung 1, 2. Am Rev Respir Dis. 1977;115:33–8.PubMedGoogle Scholar
- Li R, Jiang N, Liu Q, Huang J, Guo X, Liu F, Gao Z. Impact of air pollutants on outpatient visits for acute respiratory outcomes. Int J Environ Res Public Health. 2017;14Google Scholar
- Shvedova AA, Fabisiak JP, Kisin ER, Murray AR, Roberts JR, Tyurina YY, Antonini JM, Feng WH, Kommineni C, Reynolds J, et al. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. Am J Respir Cell Mol Biol. 2008;38:579–90.View ArticlePubMedGoogle Scholar
- Cesta MF, Ryman-Rasmussen JP, Wallace DG, Masinde T, Hurlburt G, Taylor AJ, Bonner JC. Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. Am J Respir Cell Mol Biol. 2009;43:142–51.View ArticlePubMedPubMed CentralGoogle Scholar
- Sattler C, Moritz F, Chen S, Steer B, Kutschke D, Irmler M, Beckers J, Eickelberg O, Schmitt-Kopplin P, Adler H, Stoeger T. Nanoparticle exposure reactivates latent herpesvirus and restores a signature of acute infection. Part Fibre Toxicol. 2017;14:2.View ArticlePubMedPubMed CentralGoogle Scholar
- Bisesi JH Jr, Merten J, Liu K, Parks AN, Afrooz AR, Glenn JB, Klaine SJ, Kane AS, Saleh NB, Ferguson PL, Sabo-Attwood T. Tracking and quantification of single-walled carbon nanotubes in fish using near infrared fluorescence. Environ Sci Technol. 2014;48:1973–83.View ArticlePubMedGoogle Scholar
- Li X, Castleman WL. Effects of 4-ipomeanol on bovine parainfluenza type 3 virus-induced pneumonia in calves. Vet Pathol. 1991;28:428–37.View ArticlePubMedGoogle Scholar
- Stone AE, Giguere S, Castleman WL. IL-12 reduces the severity of Sendai virus-induced bronchiolar inflammation and remodeling. Cytokine. 2003;24:103–13.View ArticlePubMedGoogle Scholar
- Sabo-Attwood T, Ramos-Nino M, Bond J, Butnor KJ, Heintz N, Gruber AD, Steele C, Taatjes DJ, Vacek P, Mossman BT. Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis. Am J Pathol. 2005;167:1243–56.View ArticlePubMedPubMed CentralGoogle Scholar
- Rowe T, Banner D, Farooqui A, Ng DC, Kelvin AA, Rubino S, Huang SS, Fang Y, Kelvin DJ. Vivo ribavirin activity against severe pandemic H1N1 influenza a/Mexico/4108/2009. J Gen Virol. 2010;91:2898–906.View ArticlePubMedGoogle Scholar
- Huang SS, Banner D, Fang Y, Ng DC, Kanagasabai T, Kelvin DJ, Kelvin AA. Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets. PLoS One. 2011;6:e27512.View ArticlePubMedPubMed CentralGoogle Scholar
- Fang Y, Banner D, Kelvin AA, Huang SS, Paige CJ, Corfe SA, Kane KP, Bleackley RC, Rowe T, Leon AJ, Kelvin DJ. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism. J Virol. 2012;86:2229–38.View ArticlePubMedPubMed CentralGoogle Scholar
- Taylor AK, Cao W, Vora KP, De La Cruz J, Shieh WJ, Zaki SR, Katz JM, Sambhara S, Gangappa S. Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice. J Infect Dis. 2013;207:501–10.View ArticlePubMedGoogle Scholar
- Tkach AV, Shurin GV, Shurin MR, Kisin ER, Murray AR, Young SH, Star A, Fadeel B, Kagan VE, Shvedova AA. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano. 2011;5:5755–62.View ArticlePubMedPubMed CentralGoogle Scholar
- Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, Belser JA, Pearce MB, Garcia-Sastre A, Tumpey TM, Palese P. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol. 2010;84:4442–50.View ArticlePubMedPubMed CentralGoogle Scholar
- Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, Mossman KL, Taylor JD, Stampfli MR. Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS One. 2010;5:e13251.View ArticlePubMedPubMed CentralGoogle Scholar
- Clifford HD, Perks KL, Zosky GR, Geogenic PM. (1)(0) exposure exacerbates responses to influenza infection. Sci Total Environ. 2015;533:275–82.View ArticlePubMedGoogle Scholar
- Fujita K, Fukuda M, Endoh S, Maru J, Kato H, Nakamura A, Shinohara N, Uchino K, Honda K. Size effects of single-walled carbon nanotubes on in vivo and in vitro pulmonary toxicity. Inhal Toxicol. 2015;27:207–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Park EJ, Roh J, Kim SN, Kang MS, Han YA, Kim Y, Hong JT, Choi K. A single intratracheal instillation of single-walled carbon nanotubes induced early lung fibrosis and subchronic tissue damage in mice. Arch Toxicol. 2011;85:1121–31.View ArticlePubMedGoogle Scholar
- Kim HM, Kang YM, Song BM, Kim HS, Seo SH. The 2009 pandemic H1N1 influenza virus is more pathogenic in pregnant mice than seasonal H1N1 influenza virus. Viral Immunol. 2012;25:402–10.View ArticlePubMedGoogle Scholar
- Khan IA, Aich N, Afrooz AN, Flora JR, Schierz PA, Ferguson PL, Sabo-Attwood T, Saleh NB. Fractal structures of single-walled carbon nanotubes in biologically relevant conditions: Role of chirality vs media conditions. Chemosphere. 2013;93:1997–2003.View ArticlePubMedGoogle Scholar
- Bisesi JH Jr, Merten J, Liu K, Parks AN, Afrooz AN, Glenn JB, Klaine SJ, Kane AS, Saleh NB, Ferguson PL. Tracking and quantification of single-walled carbon nanotubes in fish using near infrared fluorescence. Environmental Science & Technology. 2014;48:1973–83.View ArticleGoogle Scholar
- Bisesi JH Jr, Robinson SE, Lavelle CM, Ngo T, Castillo B, Crosby H, Liu K, Das D, Plazas-Tuttle J, Saleh NB, et al. Influence of the gastrointestinal environment on the bioavailability of Ethinyl estradiol Sorbed to single-walled carbon nanotubes. Environmental Science & Technology. 2017;51:948–57.View ArticleGoogle Scholar
- Ma Y, Zhang W, Zhao Z, Li M, Liu J, Wang Y. Combination of ribavirin and reduning protects mice against severe pneumonia induced by H1N1 influenza a virus. J Tradit Chin Med. 2016;36:181–6.View ArticlePubMedGoogle Scholar
- Zarogiannis SG, Noah JW, Jurkuvenaite A, Steele C, Matalon S, Noah DL. Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted a/California/04/2009 (H1N1). Life Sci. 2012;90:440–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Han Y, Ling MT, Mao H, Zheng J, Liu M, Lam KT, Liu Y, Tu W, Lau Y-L. Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice. PLoS One. 2014;9:e86166.View ArticlePubMedPubMed CentralGoogle Scholar
- Kistner O, Crowe BA, Wodal W, Kerschbaum A, Savidis-Dacho H, Sabarth N, Falkner FG, Mayerhofer I, Mundt W, Reiter M, et al. A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models. PLoS One. 2010;5:e9349.View ArticlePubMedPubMed CentralGoogle Scholar
- Otte A, Sauter M, Alleva L, Baumgarte S, Klingel K, Gabriel G. Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza a viruses in experimental mouse models. Am J Pathol. 2011;179:230–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, Leomicronn AJ, Ng DC, Almansa R, Martin-Loeches I, Ramirez P, et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection. PLoS One. 2012;7:e38214.View ArticlePubMedPubMed CentralGoogle Scholar
- Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, Yausi H. Intranasally administered Lactobacillusgasseri TMC0356 protects mice from H1N1 influenza virus infection by stimulating respiratory immune responses. World J Microbiol Biotechnol. 2011;27:411–6.View ArticleGoogle Scholar
- Lee GI, Saravia J, You D, Shrestha B, Jaligama S, Hebert VY, Dugas TR, Cormier SA. Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection. Part Fibre Toxicol. 2014;11:57.View ArticlePubMedPubMed CentralGoogle Scholar
- Jaspers I, Sheridan PA, Zhang W, Brighton LE, Chason KD, Hua X, Tilley SL. Exacerbation of allergic inflammation in mice exposed to diesel exhaust particles prior to viral infection. Part Fibre Toxicol. 2009;6:22.View ArticlePubMedPubMed CentralGoogle Scholar
- Gowdy KM, Krantz QT, King C, Boykin E, Jaspers I, Linak WP, Gilmour MI. Role of oxidative stress on diesel-enhanced influenza infection in mice. Part Fibre Toxicol. 2010;7:34.View ArticlePubMedPubMed CentralGoogle Scholar
- Esposito S, Molteni CG, Giliani S, Mazza C, Scala A, Tagliaferri L, Pelucchi C, Fossali E, Plebani A, Principi N. Toll-like receptor 3 gene polymorphisms and severity of pandemic a/H1N1/2009 influenza in otherwise healthy children. Virol J. 2012;9:270.View ArticlePubMedPubMed CentralGoogle Scholar
- Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC. Human interferons alpha, beta and omega. Growth Factors. 2004;22:243–51.View ArticlePubMedGoogle Scholar
- Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013;13:46–57.View ArticlePubMedGoogle Scholar
- Inoue K, Yanagisawa R, Koike E, Nishikawa M, Takano H. Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: possible role of oxidative stress. Free Radic Biol Med. 2010;48:924–34.View ArticlePubMedGoogle Scholar
- Hsieh WY, Chou CC, Ho CC, SL Y, Chen HY, Chou HY, Chen JJ, Chen HW, Yang PC. Single-walled carbon nanotubes induce airway hyperreactivity and parenchymal injury in mice. Am J Respir Cell Mol Biol. 2012;46:257–67.View ArticlePubMedGoogle Scholar
- Swedin L, Arrighi R, Andersson-Willman B, Murray A, Chen Y, Karlsson MC, Georen SK, Tkach AV, Shvedova AA, Fadeel B, et al. Pulmonary exposure to single-walled carbon nanotubes does not affect the early immune response against toxoplasma gondii. Part Fibre Toxicol. 2012;9:16.View ArticlePubMedPubMed CentralGoogle Scholar
- Grecco AC, Paula RF, Mizutani E, Sartorelli JC, Milani AM, Longhini AL, Oliveira EC, Pradella F, Silva VD, Moraes AS, et al. Up-regulation of T lymphocyte and antibody production by inflammatory cytokines released by macrophage exposure to multi-walled carbon nanotubes. Nanotechnology. 2011;22:265103.View ArticlePubMedGoogle Scholar
- Tumpey TM, Fenton R, Molesworth-Kenyon S, Oakes JE, Lausch RN. Role for macrophage inflammatory protein 2 (MIP-2), MIP-1α, and interleukin-1α in the delayed-type hypersensitivity response to viral antigen. J Virol. 2002;76:8050–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.View ArticlePubMedPubMed CentralGoogle Scholar
- Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell. 2015;160:816–27.View ArticlePubMedPubMed CentralGoogle Scholar
- Chiu CF, Dar HH, Kapralov AA, Robinson RAS, Kagan VE, Star A. Nanoemitters and innate immunity: the role of surfactants and bio-coronas in myeloperoxidase-catalyzed oxidation of pristine single-walled carbon nanotubes. Nano. 2017;9:5948–56.Google Scholar
- Fadeel B, Xue D, Kagan V. Programmed cell clearance: molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation. Biochem Biophys Res Commun. 2010;396:7–10.View ArticlePubMedPubMed CentralGoogle Scholar
- Lam C-W, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77:126–34.View ArticlePubMedGoogle Scholar
- Mangum JB, Turpin EA, Antao-Menezes A, Cesta MF, Bermudez E, Bonner JC. Single-walled carbon nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages in situ. Part Fibre Toxicol. 2006;3:15.View ArticlePubMedPubMed CentralGoogle Scholar
- Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci. 2004;77:117–25.View ArticlePubMedGoogle Scholar